EC Number   |
Activating Compound |
Reference |
|---|
    4.1.1.90 | ammonium sulfate |
- |
701214 |
| 4.1.1.90 | benzoylphenylalanine |
Bpa, the four Bpa peptides enhance gamma-carboxylation by 1.5-2.3fold, and the rate enhancement profiles are very similar to that of proFIX19, showing that these propeptides are recognized by the carboxylase |
696184 |
| 4.1.1.90 | decarboxylated plasma prothrombin |
activates the enzyme |
695615 |
| 4.1.1.90 | endogenous precursor |
activates the enzyme |
695615 |
| 4.1.1.90 | FLEEL |
the enzyme activity increases with increasing FLEEL peptide concentration up to 1.2 mM |
715064 |
| 4.1.1.90 | more |
enzyme activity increases 2-3fold by a vitamin K deficiency or Warfarin treatment |
695615 |
| 4.1.1.90 | N-ethyl-2-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)hexadecylamide |
2fold higher carboxylated osteocalcin synthesis in MG-63 cells in presence of the compound than with menaquinone-4. No cytotoxicity observed with concentrations up to 500 nM |
747280 |
| 4.1.1.90 | N-ethyl-2-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)tetradecylamide |
- |
747280 |
| 4.1.1.90 | N-ethyl-2-(3-methyl-1,4-dioxo-1,4-dihydronaphthalen-2-yl)tetradecylamide |
2.5fold higher carboxylated osteocalcin synthesis in MG-63 cells in presence of the compound than with menaquinone-4, No cytotoxicity observed with concentrations up to 500 nM |
747280 |
| 4.1.1.90 | proFIX 19 |
- |
701214 |
